๐Ÿฉท Fibroadenoma Follow-Up: How Often Is It Needed?

โ€œ6๊ฐœ์›” ํ›„ ๋‹ค์‹œ ์˜ค๋ผ๋Š”๋ฐโ€ฆ ์™œ์ฃ ?โ€

Fibroadenoma๋Š” ๋Œ€๋ถ€๋ถ„ ์–‘์„ฑ ์ข…๊ดด์ž…๋‹ˆ๋‹ค.

ํ•˜์ง€๋งŒ ์ดˆ์ŒํŒŒ์—์„œ BI-RADS 3๋กœ ๋ถ„๋ฅ˜๋˜๋Š” ๊ฒฝ์šฐ,

์ผ๋ฐ˜์ ์œผ๋กœ ๋‹จ๊ธฐ ์ถ”์  ๊ด€์ฐฐ(short-term follow-up) ์„ ๊ถŒํ•ฉ๋‹ˆ๋‹ค.

๐Ÿฉบ ์ผ๋ฐ˜์ ์ธ ์ถ”์  ์Šค์ผ€์ค„

๐Ÿ“Œ BI-RADS 3์ธ ๊ฒฝ์šฐ:

  • 6๊ฐœ์›” ํ›„ ์ดˆ์ŒํŒŒ
  • ์ดํ›„ 12๊ฐœ์›”
  • 24๊ฐœ์›”๊นŒ์ง€ ์•ˆ์ •์ ์ด๋ฉด ์ข…๊ฒฐ ๊ฐ€๋Šฅ

์ฆ‰,

2๋…„ ๋™์•ˆ ๋ณ€ํ™”๊ฐ€ ์—†์œผ๋ฉด ์–‘์„ฑ์œผ๋กœ ํ™•์ •ํ•˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค.

โ“ ์™œ ๋ฐ”๋กœ ์กฐ์ง๊ฒ€์‚ฌ๋ฅผ ์•ˆ ํ•˜๋‚˜์š”?

Fibroadenoma๋Š”:

  • ๋ชจ์–‘์ด ์ „ํ˜•์ ์ด๊ณ 
  • ๊ฒฝ๊ณ„๊ฐ€ ๋งค๋ˆํ•˜๊ณ 
  • wider-than-tall orientation์ด๋ฉฐ
  • ๋‚ด๋ถ€ ํ˜ˆ๋ฅ˜๊ฐ€ minimalํ•˜๊ฑฐ๋‚˜ ์—†๋Š” ๊ฒฝ์šฐ

์•” ๊ฐ€๋Šฅ์„ฑ์ด ๋งค์šฐ ๋‚ฎ์Šต๋‹ˆ๋‹ค.

๋”ฐ๋ผ์„œ

๋ถˆํ•„์š”ํ•œ ์กฐ์ง๊ฒ€์‚ฌ๋ฅผ ํ”ผํ•˜๊ธฐ ์œ„ํ•ด

์ถ”์  ๊ด€์ฐฐ์„ ์„ ํƒํ•ฉ๋‹ˆ๋‹ค.

โš ๏ธ ์ด๋Ÿฐ ๊ฒฝ์šฐ๋Š” ์žฌํ‰๊ฐ€ ํ•„์š”

  • ํฌ๊ธฐ๊ฐ€ ๋น ๋ฅด๊ฒŒ ์ฆ๊ฐ€
  • ๋ชจ์–‘์ด ๋ณ€ํ•จ
  • ๊ฒฝ๊ณ„๊ฐ€ ๋ถˆ๊ทœ์น™ํ•ด์ง
  • ๋‚ด๋ถ€ ๊ณ ํ˜• ์„ฑ๋ถ„ ๋ณ€ํ™”
  • 40์„ธ ์ดํ›„ ์ƒˆ๋กœ ๋ฐœ๊ฒฌ๋œ ๊ฒฝ์šฐ

์ด๋•Œ๋Š” ์กฐ์ง๊ฒ€์‚ฌ๋ฅผ ๊ณ ๋ คํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๐ŸŒฟ Clinical Insight

Growth rate is more important than absolute size.

A stable fibroadenoma over time strongly supports a benign diagnosis.

๐ŸŒ English Summary

Fibroadenomas categorized as BI-RADS 3 are typically followed with ultrasound at 6, 12, and 24 months.

If the lesion remains stable for 2 years, it is considered benign and follow-up may be discontinued.

Rapid growth or morphologic changes may warrant biopsy.

๊ธ€์“ด์ด

UltraLog

I share practical fetal ultrasound knowledge based on real clinical experience.